Results 121 to 130 of about 27,108,475 (305)
Cost-Benefit Analysis - Economic Tool Used to Aid Decision-Making Regarding the Distribution of Public Funds [PDF]
After 1990, the financial analysis of the phenomena that occur in firms has grown in importance. Financial analysts face new challenges as a result of Romania’s joining to the European Union. A thorough analysis of the investment decisions is required in
Lucian BUSE +2 more
core
A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham +7 more
wiley +1 more source
Economic aspects of implementation of environmental flows
Sustainable management of water resources requires leaving in the rivers a flow that ensures biological life. Since 2014, water authorities have been seeking to develop a methodology for determining environmental flows that are to reflect the inherently
Anna Dubel, Izabela Godyń
doaj
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki +7 more
wiley +1 more source
Cost-Benefit Analysis in a Framework of Stakeholder Involvement and Integrated Coastal Zone Modeling [PDF]
Active involvement of local stakeholders is currently an increasingly important requirement in European environmental regulations such as the EU Water Framework Directive (WFD) and the EU Marine Strategy Framework Directive (MSFD).
Söderqvist, Tore +4 more
core
Benefit-Cost Analysis in Public Health
This chapter gives an overview of benefit-cost analysis (BCA) and similar evaluation tools, such as cost-effectiveness analysis and technology-based standards, in the context of public health.
Lester B Lave (5455793) +1 more
core +1 more source
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos +2 more
wiley +1 more source
Accounting for the distribution of benefits & costs in benefit-cost analysis [PDF]
Benefit-cost analysis (BCA) is often viewed as measuring the efficiency of a policy independent of the distribution of its consequences. The role of distributional effects on policy choice is disputed; either: (a) the policy that maximize net benefits should be selected and distributional concerns should be addressed through other measures, such as tax
openaire +1 more source
An Aggregate Measure for Benefit-Cost Analysis [PDF]
The Kaldor-Hicks (KH) criterion has long been the standard for benefit-cost analysis, but it has also been widely criticized for ignoring equity and, arguably, moral sentiments in general.
Finkle, Aaron +2 more
core
Renewable energy cost-benefit analysis under Malaysian feed-in-tariff
Penetration of renewable energy sources in Europe have increased significantly for the past 10 years, especially in Germany. One important factor contributing to this improvement is the introduction of Feed-in Tariff (FiT).
Abdullah, A. S. +7 more
core +1 more source

